Abdel-Rahman O - Search Results

1

Incidence of Capillary Leak Syndrome as an Adverse Effect of Drugs in Cancer Patients: A Systematic Review and Meta-Analysis.

Jeong GH, Lee KH, Lee IR, Oh JH, Kim DW, Shin JW, Kronbichler A, Eisenhut M, van der Vliet HJ, Abdel-Rahman O, Stubbs B, Solmi M, Veronese N, Dragioti E, Koyanagi A, Radua J, Shin JI. Jeong GH, et al. J Clin Med. 2019 Jan 26;8(2):143. doi: 10.3390/jcm8020143. J Clin Med. 2019. PMID: 30691103 Free PMC article.

2

Risk of mucocutaneous toxicities in patients with solid tumors treated with sorafenib: an updated systematic review and meta-analysis.

Abdel-Rahman O, Fouad M. Abdel-Rahman O, et al. Expert Rev Anticancer Ther. 2014 Jun;14(6):751-60. doi: 10.1586/14737140.2014.894465. Epub 2014 Mar 26. Expert Rev Anticancer Ther. 2014. PMID: 24666215 Review.

3

Risk of thyroid dysfunction in patients with solid tumors treated with VEGF receptor tyrosine kinase inhibitors: a critical literature review and meta analysis.

Abdel-Rahman O, Fouad M. Abdel-Rahman O, et al. Expert Rev Anticancer Ther. 2014 Sep;14(9):1063-73. doi: 10.1586/14737140.2014.929501. Epub 2014 Jun 13. Expert Rev Anticancer Ther. 2014. PMID: 24927771 Review.

4

Bevacizumab-based combination therapy for advanced gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs): a systematic review of the literature.

Abdel-Rahman O, Fouad M. Abdel-Rahman O, et al. J Cancer Res Clin Oncol. 2015 Feb;141(2):295-305. doi: 10.1007/s00432-014-1757-5. Epub 2014 Jul 3. J Cancer Res Clin Oncol. 2015. PMID: 24990591 Review.

5

Risk of cardiovascular toxicities in patients with solid tumors treated with sunitinib, axitinib, cediranib or regorafenib: an updated systematic review and comparative meta-analysis.

Abdel-Rahman O, Fouad M. Abdel-Rahman O, et al. Crit Rev Oncol Hematol. 2014 Dec;92(3):194-207. doi: 10.1016/j.critrevonc.2014.06.003. Epub 2014 Jul 1. Crit Rev Oncol Hematol. 2014. PMID: 25028151 Review.

6

Correlation of cetuximab-induced skin rash and outcomes of solid tumor patients treated with cetuximab: a systematic review and meta-analysis.

Abdel-Rahman O, Fouad M. Abdel-Rahman O, et al. Crit Rev Oncol Hematol. 2015 Feb;93(2):127-35. doi: 10.1016/j.critrevonc.2014.07.005. Epub 2014 Aug 12. Crit Rev Oncol Hematol. 2015. PMID: 25139841 Review.

7

Risk of mucocutaneous toxicities in patients with solid tumors treated with everolimus; a systematic review and meta-analysis.

Abdel-Rahman O, Fouad M. Abdel-Rahman O, et al. Expert Rev Anticancer Ther. 2014 Dec;14(12):1529-36. doi: 10.1586/14737140.2014.953936. Epub 2014 Aug 27. Expert Rev Anticancer Ther. 2014. PMID: 25159115 Review.

8

Risk of cardiovascular toxicities in patients with solid tumors treated with sorafenib: an updated systematic review and meta-analysis.

Abdel-Rahman O, Fouad M. Abdel-Rahman O, et al. Future Oncol. 2014 Oct;10(12):1981-92. doi: 10.2217/fon.14.42. Future Oncol. 2014. PMID: 25386814 Review.

9

Risk of mucocutaneous toxicities in patients with solid tumors treated with sunitinib: a critical review and meta analysis.

Abdel-Rahman O, Fouad M. Abdel-Rahman O, et al. Expert Rev Anticancer Ther. 2015 Jan;15(1):129-41. doi: 10.1586/14737140.2015.985660. Epub 2014 Dec 8. Expert Rev Anticancer Ther. 2015. PMID: 25482593 Review.

10

Risk of selected gastrointestinal toxicities in patients with advanced non-small cell lung cancer receiving erlotinib: a systematic review and meta-analysis.

Abdel-Rahman O, Fouad M. Abdel-Rahman O, et al. Expert Rev Anticancer Ther. 2015 Apr;15(4):465-75. doi: 10.1586/14737140.2015.1014035. Epub 2015 Feb 9. Expert Rev Anticancer Ther. 2015. PMID: 25664933 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

343 results

Search Page

Filters